Utilization, Spending, and Price of Opioid Medications in the US Medicaid Programs Between 1991 and 2019.

ABSTRACT:

Background

The opioid epidemic and drug abuse are critical public health challenges in the United States. The number of deaths from exceeding the recommended opioid dose is increasing.

Objective

To describe the recent trends in utilization, spending, and cost of opioid medications in the US Medicaid population between 1991 and 2019.

Methods

This retrospective, descriptive study was designed to evaluate the utilization of, spending on, and cost of opioids from 1991 to 2019 in the Medicaid population. We extracted data from the Centers for Medicare & Medicaid Services national Medicaid pharmacy files. The opioids received included fentanyl, meperidine, morphine, hydromorphone, oxymorphone, hydrocodone, hydrocodone plus acetaminophen, oxycodone, oxycodone plus acetaminop

SUBMITTER: Alsultan MM 

PROVIDER: S-EPMC9038001 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature